The clinical utility of glycated hemoglobin measurements in renal failure is controversial, given numerous earlier studies showing no correlation between glycated hemoglobin and other indicators of blood glucose control in uremic subjects.
ions (7), has much the same net electrical charge as some glycated hemoglobins and cannot be separated from them by analytical methods based on ion-exchange chromatography
(7).
An affinity-chromatographic assay for glycated hemoglobin described recently by Mallia et al. (17) does not depend on the electrical charge of the molecule, but rather makes use of the binding of the glucose residues in the glycated hemoglobins to aminophenylboronic acid coupled to a carbonyl diimida.zole-activated agarose matrix (6). Carbamylated hemoglobin will not affect the results because the carbamyl group does not contain the cis-diol configuration that is recognized by the affinity method.
We evaluated this method in a group of patients with endstage renal failure, who were being treated with continuous ambulatory peritoneal dialysis. These patients were particularly interesting because a high proportion of them were diabetics (47%)and because they were exposed to a high glucose concentration (from 15 to 45 g/L) in the dialysate. In addition, such patients tend to have higher concentrations of urea in their blood than do hemodialysis patients and thus may attain very high blood concentrations of carbamylated hemoglobins.
Materials and Methods
Blood samples were collected from all of the 17 patients (nine men and eight women, fasting and nonfasting) receiving continuous ambulatory peritoneal dialysis treatment at the University of Virginia Medical Center during the twomonth period of study. Eight of the patients were diabetics, six insulin-dependent, and two noninsulin-dependent. One nondiabetic patient was obese and had nonfasting values or plasma glucose consistently exceeding 1000 mg/L. Plasma glucose values during fasting were consistently less than 1100 mgfL in the other eight nondiabetic patients. The mean age of the eight diabetic patients was 50 years (range 23-64), not significantly different from the mean age of the eight nonobese, nondiabetic patients (mean age 53 years, range 28-80).
We measured glycated hemoglobin by our modification (18) of the method of Mallia et al. (17) . In brief, we hemolyze 
We also collected paired pre-and post-dialysis blood samples from nine additional patients who were undergoing intermittent hemodialysis treatment, to assess the acute effect of hemodialysis on the concentration of glycated hemoglobin.
Results
The mean (±SE) proportion of glycated hemoglobin as measured by the affinity method was significantly higher in the diabetics (9.5% ± 1.1%) than in the nondiabetics (5.6% ± 0.2%) (Figure 1, p <0.005 by unpaired t-test with unequal  variances) . Glycated hemoglobin was not increased in any of the eight nondiabetic patients but was increased in seven of the eight diabetic patients (p <0.005, chi-square test) and in the obese patient (Figure 1) . The one diabetic patient whose glycated hemoglobin was not increased was using home monitoring of glucose; her mean concentration of plasma glucose was 790 mg/L (see below), and she had a history of frequent episodes of hypoglycemia.
Glycated hemoglobin concentration correlated significantly (r = 0.52, p <0.05) with fasting concentrations of plasma glucose (Figure 2, top) . Five of the diabetic patients monitored their glucose at home and recorded at least three glucose values at various times each day (fasting or nonfasting not specified). The mean glucose concentration for these patients, computed from the measurements of glycated hemoglobin over the preceding month, was closely reflected by the values for glycated hemoglobin (r = 0.91, p <0.05) (Figure 2, mkldle) . 
Values for glycated hemoglobin correlated

Discussion
In contrast to several previous reports (5, 6, 8, 11, 13, 15,  16) , we have found that the proportion of glycated hemoglobin does reflect control of plasma glucose in uremic patients (Figures 1 and 2) .
The discrepancy between our results and those in most previous reports was not unexpected, given the findings of Fluckiger et al. (7) , who demonstrated that the positive correlation between blood urea and hemoglobin A1 did not persist when glycated hemoglobin was measured by the thiobarbituric acid method. Fluckiger et al. reported that at least part of the apparent increase in glycated hemoglobin in uremia was caused by carbamylated hemoglobins formed from the condensation of urea-derived cyanate with Nterminal amino acids of hemoglobin (7) . Their results and ours therefore suggest that conclusions of earlier reports do not apply to measurements of glycated hemoglobins by the more specific methods involving thiobarbituric acid or boronate affinity chromatography.
Interpretation of the glycated hemoglobin values, however, requires consideration of the shortened survival time of erythrocytes in uremia, the degree of glycation of hemoglobin being dependent on the age of the erythrocytes and thus on how long their hemoglobin was exposed to the circulating plasma glucose (1,2) . Interestingly, the proportion of glycated hemoglobin was not increased in most of the nondiabetic patients we studied, despite the well-known carbohydrate intolerance of uremic patients ( 
